Questcor Pharmaceuticals, Inc. (Headquarters) Says FDA To Take More Time To Review Label Wording for Acthar

September 9, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Sept 8 (Reuters) - Questcor Pharmaceuticals Inc (QCOR.O) said U.S. health regulators extended, for the second time, review of the company's Acthar gel to treat seizures in infants.

Twitter
LinkedIn
Facebook
Email
Print

Food and Drug Administration (FDA)